Fermion

Activities: Manufacturing Ingredients

Trending Articles

  1. Sanofi invests €40m into biopharmaceutical manufacturing at its Lyon Gerland site The pharma giant has expanded its French monoclonal antibody production capabilities, while also dedicating €25m to the development of a second-gen polyclonal antibody
  2. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  3. Cleancube multi: Guardtech’s container facilities support NHS aseptic pharmacies Award-winning mobile cleanrooms offer fast, flexible solutions for facility upgrades
  4. Pharmaceutics International bolsters its prefilled syringe production capabilities The aseptic and oral dosage CDMO has invested USD $3.6m into advanced labelling, fill/finish and automated visual inspection technologies at its Hunt Valley site in Maryland, US
  5. Ardena's Oss nanomedicine facility gains full GMP approval from the Dutch Healthcare Authority The pharmaceutical manufacturing facility can produce advanced nanoparticle drug delivery systems, including lipid-based, polymeric and metal oxide nanoparticles

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

Related Content

Containment

Handling potent APIS with care and confidence

Potent active pharma ingredients require ultra careful handling and containment. ChargePoint highlights the challenges and how they were effectively and safely dealt with for contract developer and manufacturer Fermion at Espoo
Manufacturing

Fermion extends its particle engineering capabilities
Ingredients

Smart HPAPI solutions from grams to tons

Fermion’s priority and passion is to offer its clients quick-to-market HPAPI development solutions
Manufacturing

Fermion expands API facility in Hanko, Finland

The Finnish API contract development and manufacturing organisation (CDMO) is expanding its API plant with additional reactor space
You need to be a subscriber to read this article.
Click here to find out more.
Containment

CDMO strategy key to HPAPI success

As competition grows in highly potent active pharmaceutical ingredients (HPAPI) manufacturing, Arto Toivonen, President of Finnish API manufacturer Fermion, considers key factors that can ensure the successful outsourcing of projects
Subscribe now